Zynor Pharmaceutical Private Limited
About Zynor Pharmaceutical Private Limited
Data last updated:
Zynor Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 22 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85300KA2019PTC120638. Its GSTIN is 32AABCZ3177H1ZB (Kerala).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹35 Lakh. It is led by directors including Chematti Valappil Jiljith (Managing Director) and Sarika Vazhipokil.
Its last annual general meeting (AGM) was held on 17 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 9/2 6th Cross Amar Jyothinagar Near Vijayanagar, Bangalore, Karnataka, India – 560040.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.01 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹17.28 Lakh (net margin 2.5%) and EBITDA of ₹26.32 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years.
Court records list 5 cases involving the company, including 4 filed by the company; 2 cases are pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address9/2 6th Cross Amar Jyothinagar Near Vijayanagar, Bangalore, Karnataka, India – 560040
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Zynor Pharmaceutical Private Limited
The main business activity of Zynor Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Zynor Pharmaceutical Private Limited FY 2024 filings available
Zynor Pharmaceutical Private Limited reported revenue of ₹7.01 Cr (up 40% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Zynor Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 36% over three years, including 40% growth in the latest year. EBITDA rose 92% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Zynor Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹26.32 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17.28 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Zynor Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Zynor Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Zynor Pharmaceutical Private Limited
Zynor Pharmaceutical has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarika Vazhipokil | Director | 27 May 2019 | 7 Years 4 Months | Current |
| Anas Abdurahiman | Director | 27 May 2019 | 7 Years 4 Months | Current |
| Thekkekalam Vidya | Director | 27 May 2019 | 7 Years 4 Months | Current |
| Chematti Valappil Jiljith | Managing Director | 22 Jan 2019 | 7 Years 9 Months | Current |
| Navab Punathil | Director | 22 Jan 2019 | 7 Years 9 Months | Current |
| Muhammed Ihsan | Director | 22 Jan 2019 | 7 Years 9 Months | Current |
Peer Comparison of Zynor Pharmaceutical Private Limited
Zynor Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Decolene Fibres Private Limited | ₹7.02 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Delhi, India |
| Indramohan Vanijya Private Limited | ₹7.02 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Howrah, West Bengal, India |
| Organic Herbs Private Limited | ₹7.02 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Neemuch, Madhya Pradesh, India |
| Shivkeshavam Trado Private Limited | ₹7.02 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Bhilai, Chhattisgarh, India |
| Spectrovision Instruments Private Limited | ₹7.02 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Mumbai, Maharashtra, India |
| Zynor Pharmaceutical Private Limited this company | ₹7.01 Cr (FY 2024) | •••• | •••• | 40.0% | •••• | Bangalore, Karnataka, India |
| Hafiz Agro International Private Limited | ₹7.01 Cr (FY 2023) | •••• | •••• | 1317.0% | •••• | Solapur, Maharashtra, India |
| Swawlambhi Ayurveda Private Limited | ₹7.01 Cr (FY 2025) | •••• | •••• | 18565.0% | •••• | Delhi, India |
| Owg (India) Private Limited | ₹7.01 Cr (FY 2024) | •••• | •••• | 118.0% | •••• | Mumbai, Maharashtra, India |
| Crysta Electricals Private Limited | ₹7.01 Cr (FY 2025) | •••• | •••• | 109.0% | •••• | Gautambudhnagar, Uttar Pradesh, India |
| Startech Energy Private Limited | ₹7.01 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Tijara, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Zynor Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Zynor Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Zynor Pharmaceutical Private Limited
Zynor Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Zynor Pharmaceutical Private Limited
Zynor Pharmaceutical Private Limited has 5 court cases on record: 4 filed by Zynor Pharmaceutical, 1 where it is another party. 2 cases are pending and 3 are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 0 | 2 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Krishnagiri, Tamil Nadu | Criminal case | Company is another party | Pending |
| District court, Kozhikode, Kerala | Criminal case | Filed by the company against an individual | Pending |
| District court, Kozhikode, Kerala | Criminal case | Filed by the company against an individual | Disposed |
| District court, Ernakulam, Kerala | Civil suit | Filed by the company against Florex Media Pvt.Ltd | Disposed |
| District court, Kozhikode, Kerala | Criminal case | Filed by the company against an individual | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Zynor Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Zynor Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Zynor Pharmaceutical Private Limited
Zynor Pharmaceutical Private Limited has 8 board changes on record since 2019: 6 appointments and 2 cessations. The latest: Santhosh Manammel Krishnan ceased to be Director on 18 Dec 2023.
Credit Ratings, Litigation & Regulatory Alerts for Zynor Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Zynor Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Zynor Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Zynor Pharmaceutical Private Limited
Zynor Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AABCZ3177H1ZB | Kerala | Active | 02 Mar 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Zynor Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zynor Pharmaceutical Private Limited
Zynor Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 22 January 2019 (7+ years old) and is registered under CIN U85300KA2019PTC120638.
Zynor Pharmaceutical reported revenue of ₹7.01 Cr for FY 2024 (up 40% YoY).
Zynor Pharmaceutical has 6 current directors:
- Chematti Valappil Jiljith - Managing Director
- Sarika Vazhipokil - Director
- Anas Abdurahiman - Director
- Thekkekalam Vidya - Director
- Navab Punathil - Director
- Muhammed Ihsan - Director
Zynor Pharmaceutical reported a net profit of ₹17.28 Lakh (net margin 2.5%) and EBITDA of ₹26.32 Lakh (EBITDA margin 3.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Zynor Pharmaceutical is 36% over three years. In the latest year (FY 2024) revenue rose 40%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Zynor Pharmaceutical is 32AABCZ3177H1ZB, registered in Kerala.
The CIN (Corporate Identification Number) of Zynor Pharmaceutical is U85300KA2019PTC120638. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zynor Pharmaceutical has 5 court cases on record: 4 filed by the company. 2 are pending.
Zynor Pharmaceutical was incorporated on 22 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Zynor Pharmaceutical by revenue are Decolene Fibres Private Limited, Indramohan Vanijya Private Limited, Organic Herbs Private Limited, Shivkeshavam Trado Private Limited, Spectrovision Instruments Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Santhosh Manammel Krishnan ceased to be Director on 18 Dec 2023. Anas Abdurahiman was appointed as Director on 27 May 2019. Chematti Valappil Jiljith ceased to be Director on 27 May 2019. Zynor Pharmaceutical has 8 board changes on record in total.